- Home
- YQ vs SCNX Comparison
YQ vs SCNX Comparison
Compare YQ & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | YQ | SCNX |
|---|---|---|
| Founded | 2012 | 2010 |
| Country | China | United States |
| Employees | 340 | 19 |
| Industry | Other Consumer Services | Other Pharmaceuticals |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.7M | 19.0M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | YQ | SCNX |
|---|---|---|
| Price | $2.52 | $0.45 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.50 |
| AVG Volume (30 Days) | 3.1K | ★ 2.2M |
| Earning Date | 03-24-2026 | 04-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $347.88 |
| Revenue Next Year | N/A | $744.44 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.26 | $0.37 |
| 52 Week High | $6.45 | $2.60 |
Technical Indicators
Market Signals| Indicator | YQ | SCNX |
|---|---|---|
| Relative Strength Index (RSI) | 32.88 | 49.94 |
| Support Level | $2.44 | $0.39 |
| Resistance Level | $3.74 | $0.47 |
| Average True Range (ATR) | 0.14 | 0.05 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 9.62 | 35.63 |
Price Performance
Historical ComparisonAbout YQ 17 Education & Technology Group Inc.
17 Education & Technology Group Inc is an education technology company in China. It offers smart, in-school, teaching and learning SaaS offerings assist students, teachers, schoolmasters and educational authorities across China. It also offer other educational products and services that complement students' in-school learning. Geographically group operates in China.
About SCNX Scienture Holdings Inc.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.